Epidemiological and Clinical Features of COVID-19 Patients at National Emergency Hospital Wisma Atlet Kemayoran, Jakarta,Indonesia
The emergency hospital is intended to prevent transmission of COVID-19 in the community by isolating patients without symptoms, with mild or moderate symptoms. This study evaluated the clinical characteristics and outcomes of COVID-19 patients who were admitted to this facility. This retrospective study reviewed data of patients treated at the National Emergency Hospital Wisma Atlet Kemayoran in Jakarta, Indonesia, from March 23 to April 30, 2020. Patient characteristics (clinical symptoms, laboratory test results, Chest X-Ray, SARS-CoV-2 immunoserology, and RT-PCR results from nasopharyngeal/ oropharyngeal preparations) were compared between severity groups. There were 413 COVID-19 cases analyzed, of which 190 (46%) were asymptomatic, 93 (22.5%) were mild, and 130 (31.5%) were moderate cases. Most asymptomatic cases were male, with young age, and without comorbidity. Mild cases were dominated by female and young patients, while most moderate cases were male and older patients. The number of patients with comorbidities was higher in mild and moderate cases. The patient’s overall outcome was good and did not differ based on the severity of symptoms. Despite the many challenges, patients with moderate symptoms can be safely treated in the emergency hospital.
1.World Health Organization. Current health expenditure per capita (current US$); 2020 [cited 2020 Sep 21].
2.Coronavirus Disease 2019 (COVID-19) situation report-1; 2020.
3.Worldometer COVID-19 coronavirus pandemic; 2020 [cited 2020 Sep 22].
4.Pinandita A (The JP. COVID-19: Indonesia calls for global cooperation to overcome medical supply shortage; 2020.
5.Ghalia G, Arbi IA. Shortage of PPE, medical workers hindering COVID-19 fight, says Terawan. The Jakarta Post; 2020.
6. Kementerian Komunikasi dan Informatika Republik Indonesia. Miliki kapasitas 24 ribu orang, Presiden cek kesiapan Wisma Atlet tampung pasien COVID-19; 2020 [cited 2020 Sep 22].
7.Chen S, Zhang Z, Yang J, Wang J, Zhai X, Bärnighausen T, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. The Lancet. 2020;395(10232):1305–14.
8.Cai Y, Huang T, Xu G. The effects of “Fangcang, Huoshenshan, and Leishenshan” hospitals and environmental factors on the mortality of COVID-19. PeerJ. 2020;21(8):e9578.
9.Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19); 2020
10.Burhan E, Susanto A, Nasution S, Ginanjar E, Pitoyo C, Susilo A, et al. Protokol tata laksana COVID-19. 3rd edition. Jakarta: PDPI, PERKI, PAPDI, PERDATIN, AIDAI press; 2020.
11.Zhao W, Yu S, Zha X, Wang N, Pang Q, Li D, et al. Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study. medRxiv; 2020.
12.Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. Journal of Infection. 2020;80(4):401–6.
13.Michelen M, Jones N, Stavropoulou C. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases?; 2020 [cited 2020 Sep 12]
14.Ma C, Gu J, Hou P, Zhang L, Bai Y, Guo Z, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv; 2020.
15.Swann O, Holden K, Turtle L, Pollock L, Fairfield C, Drake T, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;(370):m3249.
16.Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. Journal of Infection. 2020;80(4):401–6.
17. Noor F, Islam M. Prevalence of clinical manifestations and comorbidities of coronavirus (COVID-19) infection: a meta-analysis. Fortune Journal of Health Sciences. 2020;55–97.
18.Long Q-X, Tang X-J, Shi Q-L, Li Q, Deng H-J, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine. 2020;26:1200–4.
19.Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clinical Infectious Diseases. 2019;(71):2688–94.
20.Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. Journal of Infection. 2020;(80):656–65.
21.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–62.
- There are currently no refbacks.